Market revenue in 2022 | USD 3.2 million |
Market revenue in 2030 | USD 6.8 million |
Growth rate | 9.7% (CAGR from 2022 to 2030) |
Largest segment | Pcr-based enzyme synthesis |
Fastest growing segment | PCR-based Enzyme Synthesis |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Solid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis |
Key market players worldwide | GenScript ProBio, Azenta Inc, Twist Bioscience Corp, ProteoGenix, Biomatik Corporation, NanHua Bio-medicine, Thermo Fisher Scientific Inc, Integrated DNA Technologies, Origene Technologies, ProMab Biotechnologies Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene synthesis (research use) market will help companies and investors design strategic landscapes.
Pcr-based enzyme synthesis was the largest segment with a revenue share of 37.5% in 2022. Horizon Databook has segmented the Kuwait gene synthesis (research use) market based on solid-phase synthesis, chip-based synthesis, pcr-based enzyme synthesis covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait gene synthesis (research use) market, including forecasts for subscribers. This country databook contains high-level insights into Kuwait gene synthesis (research use) market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account